{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:20:32Z","timestamp":1777515632718,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.thromres.2013.11.023","type":"journal-article","created":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T14:01:31Z","timestamp":1385906491000},"page":"440-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy"],"prefix":"10.1016","volume":"133","author":[{"given":"Yoshiki","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuki","family":"Naitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ikejiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Mastumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koshi","family":"Ohishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Hosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2013.11.023_bb0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2013.11.023_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2169\/internalmedicine.49.2706","article-title":"Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008","volume":"49","author":"Fujimura","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.thromres.2013.11.023_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02981975","article-title":"Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome","volume":"75","author":"Fujimura","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.thromres.2013.11.023_bb0020","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura","volume":"307","author":"Moake","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2013.11.023_bb0025","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","article-title":"Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura","volume":"276","author":"Zheng","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2013.11.023_bb0030","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.023_bb0035","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is depend on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.023_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2013.11.023_bb0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.thromres.2006.04.007","article-title":"Decreased ADAMTS13 activity in plasma from patients with thrombotic thrombocytopenic purpura","volume":"119","author":"Kobayashi","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.11.023_bb0050","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ajh.2830390106","article-title":"Plasma Thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation","volume":"39","author":"Wada","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.thromres.2013.11.023_bb0055","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/107602969800400309","article-title":"Increased plasma soluble-adhesion molecules in patients with thrombotic thrombocytopenic purpura and those with disseminated intravascular coagulation","volume":"4","author":"Shimura","year":"1998","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.thromres.2013.11.023_bb0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12185-010-0732-4","article-title":"Elevated Von Willebrand factor propeptide for the diagnosis of thrombotic microangiopathy and for predicting a poor outcome","volume":"93","author":"Ito-Habe","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.thromres.2013.11.023_bb0065","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V88.8.2951.bloodjournal8882951","article-title":"Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D- vasopressin in humans","volume":"88","author":"Borchiellini","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.023_bb0070","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1182\/blood-2006-09-043117","article-title":"VWF propeptide: a useful marker in VWD","volume":"108","author":"Federici","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.023_bb0075","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.thromres.2011.10.011","article-title":"Plasma ADAMTS13, von Willebrand Factor (VWF) and VWF Propeptide Profiles in Patients with DIC and Related Diseases","volume":"129","author":"Habe","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.11.023_bb0080","doi-asserted-by":"crossref","first-page":"23528","DOI":"10.1074\/jbc.272.38.23528","article-title":"A novel association of Fc receptor gamma-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets","volume":"272","author":"Tsuji","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2013.11.023_bb0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-cellbio-092910-154013","article-title":"Transmembrane collagen receptors","volume":"27","author":"Leitinger","year":"2011","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.thromres.2013.11.023_bb0090","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1182\/blood-2004-04-1549","article-title":"Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase","volume":"104","author":"Gardiner","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.023_bb0095","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/j.1538-7836.2007.02590.x","article-title":"Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases","volume":"5","author":"Gardiner","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.11.023_bb0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-1-61779-307-3_22","article-title":"Platelet receptor shedding","volume":"788","author":"Gardiner","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.thromres.2013.11.023_bb0105","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1160\/TH11-10-0745","article-title":"Focusing on plasma glycoprotein VI","volume":"107","author":"Al-Tamimi","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.11.023_bb0110","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/STROKEAHA.110.602532","article-title":"Soluble glycoprotein VI is raised in the plasma of patients with acute ischemic stroke","volume":"42","author":"Al-Tamimi","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2013.11.023_bb0115","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1182\/blood-2010-08-301523","article-title":"Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa","volume":"117","author":"Al-Tamimi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.023_bb0120","doi-asserted-by":"crossref","unstructured":"Nurden P, Tandon N, Takizawa H, Couzi L, Morel D, Fiore M, et al.,: An acquired inhibitor to the GPVI platelet collagen receptor in a patient with lupus nephritis. J Thromb Haemost; 7: 1541-1549.","DOI":"10.1111\/j.1538-7836.2009.03537.x"},{"key":"10.1016\/j.thromres.2013.11.023_bb0125","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00395-009-0779-7","article-title":"Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS)","volume":"104","author":"Bigalke","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.thromres.2013.11.023_bb0130","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1537-2995.2002.00100.x","article-title":"Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity","volume":"42","author":"Mori","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.thromres.2013.11.023_bb0135","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards a definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.11.023_bb0140","unstructured":"Hosoka Y, Naitoh K, Honda M: Novel platelet activation marker and method for determination thereof, European Patent Application publication No. EP2000802 A1, published on December 10, 2007."},{"key":"10.1016\/j.thromres.2013.11.023_bb0145","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI32513","article-title":"A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI\/Fc receptor gamma-chain complex","volume":"118","author":"Takayama","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2013.11.023_bb0150","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1538-7836.2006.01942.x","article-title":"Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis","volume":"4","author":"Wada","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.11.023_bb0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/09537100802710286","article-title":"Measuring soluble platelet glycoprotein VI in human plasma by ELISA","volume":"20","author":"Al-Tamimi","year":"2009","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2013.11.023_bb0160","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1373\/clinchem.2010.158527","article-title":"Sandwich immunoassay for soluble glycoprotein VI in patients with symptomatic coronary artery disease","volume":"57","author":"Bigalke","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.thromres.2013.11.023_bb0165","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1182\/blood-2011-10-386607","article-title":"Pathologic shear triggers shedding of vascular receptors: a novel mechanism for down-regulation of platelet glycoprotein VI in stenosed coronary vessels","volume":"119","author":"Al-Tamimi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.11.023_bb0170","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3109\/09537104.2012.746455","article-title":"Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischemic stroke","volume":"24","author":"Wurster","year":"2013","journal-title":"Platelets"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813005598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813005598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T03:59:02Z","timestamp":1597118342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384813005598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0049384813005598"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.11.023","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2013.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}